JP2018529346A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529346A5
JP2018529346A5 JP2018515530A JP2018515530A JP2018529346A5 JP 2018529346 A5 JP2018529346 A5 JP 2018529346A5 JP 2018515530 A JP2018515530 A JP 2018515530A JP 2018515530 A JP2018515530 A JP 2018515530A JP 2018529346 A5 JP2018529346 A5 JP 2018529346A5
Authority
JP
Japan
Prior art keywords
seq
monocytes
cpg
region
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018515530A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018529346A (ja
Filing date
Publication date
Priority claimed from GBGB1516975.8A external-priority patent/GB201516975D0/en
Application filed filed Critical
Publication of JP2018529346A publication Critical patent/JP2018529346A/ja
Publication of JP2018529346A5 publication Critical patent/JP2018529346A5/ja
Pending legal-status Critical Current

Links

JP2018515530A 2015-09-25 2016-09-22 免疫細胞、特に単球の同定のためのエピジェネティックマーカーとしてのｐａｒｋ２ Pending JP2018529346A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1516975.8 2015-09-25
GBGB1516975.8A GB201516975D0 (en) 2015-09-25 2015-09-25 PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes
PCT/EP2016/072594 WO2017050925A1 (en) 2015-09-25 2016-09-22 Park2 as epigenetic marker for the identification of immune cells, in particular monocytes

Publications (2)

Publication Number Publication Date
JP2018529346A JP2018529346A (ja) 2018-10-11
JP2018529346A5 true JP2018529346A5 (enExample) 2019-10-31

Family

ID=54544104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018515530A Pending JP2018529346A (ja) 2015-09-25 2016-09-22 免疫細胞、特に単球の同定のためのエピジェネティックマーカーとしてのｐａｒｋ２

Country Status (7)

Country Link
US (1) US11761041B2 (enExample)
EP (1) EP3353319B1 (enExample)
JP (1) JP2018529346A (enExample)
CN (2) CN108026590B (enExample)
CA (1) CA2999614C (enExample)
GB (1) GB201516975D0 (enExample)
WO (1) WO2017050925A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102017125013B4 (de) * 2017-10-25 2019-10-17 Epiontis Gmbh MCC als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere basophiler Granulozyten
DE102017125150B4 (de) * 2017-10-26 2019-10-10 Epiontis Gmbh Endosialin (CD248) als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere naïver CD8+ T-Zellen
DE102017125335B4 (de) * 2017-10-27 2019-10-17 Epiontis Gmbh Amplikon-Region als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere nicht-klassischer Monozyten
HK1256212A2 (zh) * 2018-12-27 2019-09-13 汪恩光 拉动式的换挡传动系统及食物料理机
WO2022191293A1 (ja) * 2021-03-12 2022-09-15 エーザイ・アール・アンド・ディー・マネジメント株式会社 全単球及びｃｄ１６陽性単球の割合の測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1826279T3 (da) * 2006-02-28 2011-09-05 Charite Universitaetsmedizin Detektering og kvalitetskontrol af regulatoriske t-celler vha. DNA-metyleringsanalyse af FoxP3--genet
CA2671270A1 (en) * 2006-12-29 2008-07-17 Asuragen, Inc. Mir-16 regulated genes and pathways as targets for therapeutic intervention
EP2248913B1 (en) * 2009-04-28 2016-10-05 Epiontis GmbH GNLY as epigenetic marker for the identification of CD56-expressing natural killer cells
EP2558594A2 (en) * 2010-04-16 2013-02-20 Koninklijke Philips Electronics N.V. Methods for the analysis of breast cancer disorders
US20130129668A1 (en) * 2011-09-01 2013-05-23 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
WO2013067451A2 (en) * 2011-11-04 2013-05-10 Population Diagnostics Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
CN107941681B (zh) * 2013-04-19 2021-07-30 艾皮恩蒂斯有限公司 鉴定生物样品中定量细胞组成的方法

Similar Documents

Publication Publication Date Title
Witkowski et al. Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia
Wong et al. Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches
JP2018529345A5 (enExample)
JP2018529346A5 (enExample)
CA2904658C (en) Method for identifying the quantitative cellular composition in a biological sample
Jara-Acevedo et al. Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications
Halbritter et al. Epigenomics and single-cell sequencing define a developmental hierarchy in Langerhans cell histiocytosis
Konigsberg et al. Molecular signatures of idiopathic pulmonary fibrosis
NZ786185A (en) Determination of base modifications of nucleic acids
JP2012511917A5 (enExample)
CN109906381B (zh) 鉴别、靶向以及分离人树突细胞(dc)前体“前dc”的方法及其用途
WO2007121276A3 (en) Enrichment of circulating fetal dna
JP2018534910A5 (enExample)
Paludan et al. Use of the polymerase chain reaction in quantification of interleukin 8 mRNA in minute epidermal samples
Wojciech et al. The same self-peptide selects conventional and regulatory CD4+ T cells with identical antigen receptors
CN107142320A (zh) 用于检测肝癌的基因标志物及其用途
HK1257122A1 (zh) Lrp5作为用於鉴定免疫细胞特别是b细胞的表观遗传标志物
Tomusiak et al. Development of a novel epigenetic clock resistant to changes in immune cell composition
US20200270683A1 (en) Methods for obtaining embryonic stem cell dna methylation signatures
CN112226440B (zh) 一种遗传性原发不孕的致病突变及其检测试剂
CN103911439A (zh) 系统性红斑狼疮羟甲基化状态的差异表达基因的分析方法和应用
JP6113159B2 (ja) ナチュラルキラー細胞を同定するエピジェネティックマーカー
CN103275987B (zh) Aqp5基因突变体及其应用
JP2021502806A5 (enExample)
El-Ahmad et al. Liquid biopsy in neuropsychiatric disorders: a step closer to precision medicine